… In this section, we will discuss the possible role played by anti-IL6, anti-IL-1, JAK
inhibitors, corticosteroids, antimalarials, heparins, and immunoglobulins, particularly in the …

… treatment protocol. This review provides insights into the evidence-based evolving role of
favipiravir in the management of COVID-19 … inclusion in the treatment protocols of COVID-19. …

… hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform
trial … of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with …

… coronavirus 2 (SARS-… treatment options available, to consider the future of this global
pandemic, and to identify some potential options that could revolutionize the treatment of COVID-19…

… hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform
trial … of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with …

… Due to incompleteness of subgroup data, we are uncertain whether there is a possible
benefit of remdesivir for the treatment of COVID‐19 patients receiving low‐flow oxygen therapy …

… %) in a cohort of 85 patients who died from COVID-19 [83,92]. These observations are in …
to morbidity and mortality in COVID-19, MERS and SARS. One possible explanation is the …

… coronavirus disease 2019 (COVID-19) pandemic in 2020. Despite the worsening trends
of COVID-19… to have significant efficacy in clinical treatment of COVID-19 patients in large-scale …

… treatment effect.We agree with Olalla that it is important to record the use of concomitant
medications during the trial and to evaluate the possible … intended as treatment for Covid-19, is …

… for the treatment of COVID-19. Novel … COVID-19. This review article examines the evidence
behind the potential use of these leading drug candidates for the treatment of COVID-19. The …